sincalide (WellSpring/InfaCare)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesincalide (WellSpring/InfaCare)
Drug Alias Namecholecystokinin octapeptide (WellSpring)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptor
Therapy Area/IndicationsIleus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWellspring
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInfacare Pharmaceutical CorpWellspring
Active IndicationsN/A
Inactive IndicationsIleus

Other Information

ATC CodeN/A
Related LinksN/A